Clorazepate Dipotassium
Product Images NDC 21695-434

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 21695-434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A6cc08b8 146e 430f Af39 8b866698b997 01)

Chemical structure diagram of Clorazepate Dipotassium showing molecular bonds and the positioning of atoms including chlorine, nitrogen, oxygen, phenyl group, and potassium with the associated potassium hydroxide (KOH) molecule.*

FDA Label Image

Clorazepate Dipotassium 3.75mg (A6cc08b8 146e 430f Af39 8b866698b997 02)

Clorazepate Dipotassium 3.75 mg tablets label showing 60-count bottle packaging. The label includes text indicating the active ingredient and strength, prescription-only status, a Product ID, lot number, expiration date placeholders, and manufacturer information for Taro Pharmaceutical Industries Ltd. The packaging is distributed by Rebel Distributors Corp and references Physician Partners as the packager. Storage instructions to keep the product between 15 to 30°C and out of reach of children are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.